
Pharma
What new PBM reforms mean for pharma
Analysis of PBMs pricing, exploring the key drivers, future outlook, and impact of this critical sector on the broader healthcare industry.

Pharma
What new PBM reforms mean for pharma
Pharma
Eli Lilly switches from Big 3 PBM to alternative transparent rival

Pharma
FTC halts PBM lawsuit

Pharma
Pharma leaders talk the biggest trends of 2024
Pharma
Diabetes advocates back FTC lawsuit against PBMs
Pharma
FTC sues PBMs, alleging they artificially inflated insulin costs
Pharma
Drugs left off PBM lists can lead to worse patient outcomes, higher costs